Latest Listings And Ipos News

L1 Long Short Fund reported a 7.2% net return for FY2024-25 and announced a shift to quarterly dividends, reflecting confidence despite a challenging market environment.

Clime Investment Management’s CIWO securities have been suspended from trading due to regulatory non-compliance, raising questions about the company’s next steps and investor impact.

L1 Long Short Fund Limited reports robust investment returns well above the ASX200 benchmark and announces a shift to quarterly dividends starting December 2025, signaling confidence in sustained growth.

Life360, Inc. reported robust Q3 2025 financial results driven by subscription and partnership revenue growth, alongside a leadership transition and strategic capital moves. The company also announced a major acquisition to bolster its advertising platform.

Locate Technologies Limited has officially launched its IPO on the New Zealand Exchange, aiming to raise NZ$1 million as part of its transition to a new parent company, Locate NZ. This move aligns with the company’s broader strategy, including its Bitcoin Treasury approach and long-term growth ambitions.

Lincoln Minerals Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, confirming no undisclosed information is driving the activity.

Mayne Pharma has received notice of Cosette Pharmaceuticals' intention to appeal a court ruling in their acquisition dispute, potentially delaying the proposed takeover. The legal saga continues as key approvals and hearings loom.

Associate Global Partners Limited (AGP) reported robust FY25 results, with funds under management climbing to $1.464 billion, driven by stellar investment returns and successful capital raisings. The firm is advancing its distribution reach and launching new products to sustain momentum.

Altair Minerals has raised A$13 million through an institutional placement led by 1832 Asset Management, fully funding an extensive drilling program at its Greater Oko Project set to begin early next year.

WAM Income Maximiser Limited has declared fully franked dividends for November and December 2025, supported by a 10.3% portfolio gain since inception and positive guidance for early 2026.

Invex Therapeutics has appointed two new non-executive directors and joint company secretaries, signaling a refreshed governance structure alongside a change of company address.

StepChange Holdings has locked in $11 million in new debt facilities with Westpac, enhancing its financial flexibility to accelerate growth and strategic acquisitions.